Avanafil for treatment of erectile dysfunction: review of its potential.
about
A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafilSwitching from nitrate therapy to ranolazine in patients with coronary artery disease receiving phosphodiesterase type-5 inhibitors for erectile dysfunctionThe role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesQuality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancerAvanafil for erectile dysfunction in elderly and younger adults: differential pharmacology and clinical utility.
P2860
Avanafil for treatment of erectile dysfunction: review of its potential.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Avanafil for treatment of erectile dysfunction: review of its potential.
@en
type
label
Avanafil for treatment of erectile dysfunction: review of its potential.
@en
prefLabel
Avanafil for treatment of erectile dysfunction: review of its potential.
@en
P2860
P921
P356
P1476
Avanafil for treatment of erectile dysfunction: review of its potential.
@en
P2093
Jeffery D Evans
Ryan M Burke
P2860
P304
P356
10.2147/VHRM.S26712
P407
P577
2012-08-29T00:00:00Z